The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy.
暂无分享,去创建一个
[1] A. Prokhorov,et al. Development and implementation of a tobacco cessation training program for students in the health professions. , 2003, Journal of cancer education : the official journal of the American Association for Cancer Education.
[2] E. Gilpin,et al. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. , 2002, JAMA.
[3] T. Hu,et al. The benefits of switching smoking cessation drugs to over-the-counter status. , 2002, Health economics.
[4] M. Ryan,et al. Effectiveness of a Pharmacist‐Based Smoking‐Cessation Program and Its Impact on Quality of Life , 2002, Pharmacotherapy.
[5] A. Segal,et al. Patients' views of pharmacists as providers of smoking cessation services. , 2002, Journal of the American Pharmaceutical Association.
[6] A. Mcalister,et al. Smoking cessation activities by pharmacists in East Texas. , 2002, Journal of the American Pharmaceutical Association.
[7] Stephen J. Hellebusch,et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. , 2002, Addiction.
[8] N. Rigotti,et al. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. , 2002, American journal of public health.
[9] M. Doescher,et al. Pilot study of enhanced tobacco-cessation services coverage for low-income smokers. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[10] D. T. Kennedy,et al. Development and implementation of a smoking cessation clinic in community pharmacy practice. , 2002, Journal of the American Pharmaceutical Association.
[11] R. E. Small,et al. Results of a smoking cessation clinic in community pharmacy practice. , 2002, Journal of the American Pharmaceutical Association.
[12] Mary T. Roth,et al. Use of Bupropion SR in a Pharmacist‐Managed Outpatient Smoking‐Cessation Program , 2001, Pharmacotherapy.
[13] D. M. Barbour. Development and implementation of a tobacco consultation program for managed care pharmacists. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[14] M. Lahoz,et al. Smoking cessation activities in South Carolina community pharmacies. , 2000, Journal of the American Pharmaceutical Association.
[15] S. Shiffman,et al. Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998. , 2000, MMWR. Morbidity and mortality weekly report.
[16] T. Brock,et al. An evaluation of smoking cessation-related activities by pharmacists. , 2000, Journal of the American Pharmaceutical Association.
[17] Mc Fiore,et al. Treating Tobacco Use and Dependence , 2000 .
[18] D. Schroeder,et al. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. , 1999, American journal of public health.
[19] R. West,et al. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. , 1999, Archives of internal medicine.
[20] M. Fiore,et al. Does over-the-counter nicotine replacement therapy improve smokers’ life expectancy? , 1998, Tobacco control.
[21] P. Donnan,et al. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland , 1998, Tobacco control.
[22] D. Ferry,et al. Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies , 1998, Tobacco control.
[23] S. Shiffman,et al. Public health benefit of over-the-counter nicotine medications. , 1997, Tobacco control.
[24] K. Overvad,et al. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. , 1997, American journal of epidemiology.
[25] G. Oster,et al. The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum"). , 1996, Medical care.
[26] M. Smith,et al. Pharmacist counseling and outcomes of smoking cessation. , 1995, American pharmacy.
[27] W. Baluch. Pharmacists' role in a smoking-cessation program at a health maintenance organization. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[28] N. L. Lee,et al. Pharmacists' role in a smoking-cessation program at a managed health care organization. , 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[29] B. Rimer,et al. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. , 1994, JAMA.
[30] P. Hauri,et al. Serum nicotine and cotinine levels during nicotine‐patch therapy , 1993, Clinical pharmacology and therapeutics.
[31] L. Kozlowski,et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.